by bureau Peppr | 13 September, 2023 | News
BioConnection congratulates BioLineRx with their FDA approval of Aphexda. We are proud that we have been able to support BioLineRx since the start of the Motixafortide BL-8040 project (and even before) and be their proud partner through all the clinical phases. It is...
by bureau Peppr | 22 April, 2022 | News
New capital secures growth acceleration in services for small to medium sized biopharmaceutical companies and further enhancement of quality control and innovative power Oss, The Netherlands, 22 April 2022 BioConnection, an independent CDMO (Contract Development...
by bureau Peppr | 29 November, 2021 | News
Oss, The Netherlands, 29 November 2021 BioConnection, an independent CDMO (Contract Development Manufacturing Organization) based in Oss, The Netherlands, specialized in GMP-certified manufacturing of sterile drug products in vials and syringes, today announced that...
by bureau Peppr | 28 June, 2021 | News
Oss, The Netherlands, June 28, 2021. BioConnection received today from the Dutch Healthcare Inspectorate (IGJ) the GMP certification and manufacturing license for their new large scale filling line BioConnection B.V., an independent CMO (Contract Manufacturing...
by bureau Peppr | 10 February, 2021 | News
With the EU and US GMP capabilities from our facility in Oss, BioConnection is proud to assist VarmX to accelerate the GMP manufacturing trajectory and bring VMX-C001 into clinical trials and ultimately to patients who currently have limited options to effective and...
by bureau Peppr | 23 December, 2020 | News
BioConnection announces that it is collaborating with AdaptVac for the Drug Product manufacture of their COVID-19 vaccine in its state-of-the-art-GMP manufacturing facility in the Netherlands. AdaptVac aims to accelerate the development of safe and efficacious...
